Eagle Capital Management, LLC on Humana Inc.
Thesis
Humana is another expression of Eagle's view that managed-care profitability is entering a multi-year recovery. Industry margins have been pressured by Medicare Advantage and Medicaid economics, leaving substantial room for earnings improvement if pricing and costs normalize. Eagle sees operational progress at Humana and expects significantly improved Star ratings to support the recovery.
“Humana is also making good strides, and we expect significantly improved Star ratings for the company later this year.”
Key risks
- Medicare Advantage cost and pricing pressures could remain elevated.
- The thesis depends partly on improvement in Humana's Star ratings.